Effect of combined aspirin and statin therapy on mortality reduction in sepsis-induced myocardial injury

Authors:

Abstract
Introduction: Sepsis-induced myocardial injury (SIMI) is a severe complication with high mortality and limited effective treatments. Although combined aspirin and statin therapy is cardioprotective in coronary artery disease, its impact on SIMI outcomes remains unclear. Methods: Using the MIMIC-IV database, we evaluated the association of combined aspirin and statin therapy with 28-day, 90-day, and 1-year mortality in SIMI patients using multivariable Cox regression and Kaplan-Meier analysis. Robustness was assessed via floating absolute risk analysis. External validation was performed in an independent ICU cohort. Results: Among 1,884 SIMI patients, 119 received combination therapy. Compared to those without aspirin or statin, combination therapy was associated with significantly lower mortality at 28 days (11.8% vs. 41.9%; HR = 0.22), 90 days (15.1% vs. 44.8%; HR = 0.23), and 1 year (29.4% vs. 50.9%; HR = 0.38) (all P < 0.001). The combination consistently showed the greatest risk reduction. Subgroup analysis confirmed consistent benefits. External validation (n = 4,002) confirmed a lower 28-day mortality risk with combination therapy (HR = 0.48; P < 0.001). Conclusion: Combined aspirin and statin therapy is associated with reduced mortality and improved outcomes in SIMI patients.
Funding Information
  • National Natural Science Foundation of China (82170352)
  • National Natural Science Foundation of China (82472193)

This publication has 30 references indexed in Scilit: